Therapeutic Radionuclides: Biophysical and Radiobiologic Principles
- 30 September 2008
- journal article
- review article
- Published by Elsevier BV in Seminars in Nuclear Medicine
- Vol. 38 (5), 358-366
- https://doi.org/10.1053/j.semnuclmed.2008.05.002
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- MIRD Continuing Education: Bystander and Low Dose-Rate Effects: Are These Relevant to Radionuclide Therapy?Journal of Nuclear Medicine, 2007
- 123I-ITdU-Mediated Nanoirradiation of DNA Efficiently Induces Cell Kill in HL60 Leukemia Cells and in Doxorubicin-, -, or -Radiation-Resistant Cell LinesJournal of Nuclear Medicine, 2007
- Inhibitory and Stimulatory Bystander Effects are Differentially Induced by Iodine-125 and Iodine-123Radiation Research, 2006
- Therapeutic potential of 5‐[125I]iodo‐2′‐deoxyuridine and methotrexate in the treatment of advanced neoplastic meningitisInternational Journal of Radiation Biology, 2004
- The Amazing World of Auger ElectronsInternational Journal of Radiation Biology, 2004
- Tumor Therapy with Targeted Atomic NanogeneratorsScience, 2001
- Biochemical Modulation by 5-Fluorouracil and 1-Folinic Acid of Tumor Uptake of Intra-Arterial 5-[123I]Iodo-2'-Deoxyuridine in Patients with Liver Metastases from Colorectal CancerActa Oncologica, 1996
- Radioimmunotherapy of athymic mice bearing human colon carcinomas with monoclonal antibody B72.3: Histological and autoradiographic study of effects on tumors and normal organsEuropean Journal of Cancer and Clinical Oncology, 1987
- The in Vitro Radiobiology of Astatine-211 DecayRadiation Research, 1986
- Astatine-211—Tellurium Radiocolloid Cures Experimental Malignant AscitesScience, 1981